3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review

The Food and Drug Administration (FDA) granted breakthrough therapy status to 3,4-methyl​enedioxy​methamphetamine-assisted therapy (MDMA-AT) in 2017 due to preliminary evidence supporting its efficacy and safety in treating post-traumatic stress disorder (PTSD). A series of six phase-II clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Inouye, Ann, Wolfgang, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337778/
https://www.ncbi.nlm.nih.gov/pubmed/35915689
http://dx.doi.org/10.7759/cureus.26402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337778/
https://www.ncbi.nlm.nih.gov/pubmed/35915689
http://dx.doi.org/10.7759/cureus.26402

Ejemplares similares